BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28052660)

  • 21. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Nguyen R; Jett K; Harris GJ; Cai W; Friedman JM; Mautner VF
    J Neurooncol; 2014 Jan; 116(2):307-13. PubMed ID: 24166582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.
    Arshi A; Tajudeen BA; St John M
    Oral Oncol; 2015 Dec; 51(12):1088-94. PubMed ID: 26442813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.
    Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M
    Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature.
    Yu YH; Wu JT; Ye J; Chen MX
    World J Surg Oncol; 2016 May; 14():142. PubMed ID: 27159980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors.
    Kourea HP; Bilsky MH; Leung DH; Lewis JJ; Woodruff JM
    Cancer; 1998 Jun; 82(11):2191-203. PubMed ID: 9610699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.
    Hagel C; Zils U; Peiper M; Kluwe L; Gotthard S; Friedrich RE; Zurakowski D; von Deimling A; Mautner VF
    J Neurooncol; 2007 Apr; 82(2):187-92. PubMed ID: 17111191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution.
    Anghileri M; Miceli R; Fiore M; Mariani L; Ferrari A; Mussi C; Lozza L; Collini P; Olmi P; Casali PG; Pilotti S; Gronchi A
    Cancer; 2006 Sep; 107(5):1065-74. PubMed ID: 16881077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma.
    Bernthal NM; Putnam A; Jones KB; Viskochil D; Randall RL
    J Surg Oncol; 2014 Dec; 110(7):813-6. PubMed ID: 25111615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant peripheral nerve sheath tumor in children: A single-institute retrospective analysis.
    An HY; Hong KT; Kang HJ; Choi JY; Hong C; Kim HY; Choi TH; Kang CH; Kim HS; Cheon JE; Park SH; Park JD; Park KD; Shin HY
    Pediatr Hematol Oncol; 2017 Nov; 34(8):468-477. PubMed ID: 29286874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
    Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Goryń T; Zdzienicki M; Morysiński T; Rutkowski P
    Surg Oncol; 2020 Dec; 35():276-284. PubMed ID: 32949967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.
    Le Guellec S; Decouvelaere AV; Filleron T; Valo I; Charon-Barra C; Robin YM; Terrier P; Chevreau C; Coindre JM
    Am J Surg Pathol; 2016 Jul; 40(7):896-908. PubMed ID: 27158754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors.
    Wakeman KM; Zhang QS; Bandhlish A; Cranmer LD; Ricciotti RW; Mantilla JG
    Am J Clin Oncol; 2022 Jan; 45(1):28-35. PubMed ID: 34962906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Owosho AA; Estilo CL; Huryn JM; Chi P; Antonescu CR
    Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous epithelioid malignant peripheral nerve sheath tumour: a clinicopathological analysis of 11 cases.
    Luzar B; Shanesmith R; Ramakrishnan R; Fisher C; Calonje E
    Histopathology; 2016 Jan; 68(2):286-96. PubMed ID: 26096054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
    Moretti VM; Crawford EA; Staddon AP; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2011 Aug; 34(4):417-21. PubMed ID: 20838322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant peripheral nerve sheath tumours in neurofibromatosis 1.
    Evans DG; Baser ME; McGaughran J; Sharif S; Howard E; Moran A
    J Med Genet; 2002 May; 39(5):311-4. PubMed ID: 12011145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.